Literature DB >> 16775337

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.

Jonathan S Towner1, Marina L Khristova, Tara K Sealy, Martin J Vincent, Bobbie R Erickson, Darcy A Bawiec, Amy L Hartman, James A Comer, Sherif R Zaki, Ute Ströher, Filomena Gomes da Silva, Fernando del Castillo, Pierre E Rollin, Thomas G Ksiazek, Stuart T Nichol.   

Abstract

In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different ( approximately 7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.

Entities:  

Mesh:

Year:  2006        PMID: 16775337      PMCID: PMC1488971          DOI: 10.1128/JVI.00069-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Marburg fever, Democratic Republic of the Congo.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-05-14

2.  Characterization of the L gene and 5' trailer region of Ebola virus.

Authors:  V E Volchkov; V A Volchkova; A A Chepurnov; V M Blinov; O Dolnik; S V Netesov; H Feldmann
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

3.  Marburg virus disease, Angola.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-04-01

4.  Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  T G Ksiazek; P E Rollin; A J Williams; D S Bressler; M L Martin; R Swanepoel; F J Burt; P A Leman; A S Khan; A K Rowe; R Mukunu; A Sanchez; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; M C Georges-Courbot; M Capron; J Lansoud-Soukate; P Debré; S P Fisher-Hoch; J B McCormick; A J Georges
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

6.  Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda.

Authors:  Anthony Sanchez; Pierre E Rollin
Journal:  Virus Res       Date:  2005-10       Impact factor: 3.303

7.  Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-04-01       Impact factor: 17.586

8.  ELISA for the detection of antibodies to Ebola viruses.

Authors:  T G Ksiazek; C P West; P E Rollin; P B Jahrling; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Potential mammalian filovirus reservoirs.

Authors:  A Townsend Peterson; Darin S Carroll; James N Mills; Karl M Johnson
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

10.  SARS transmission pattern in Singapore reassessed by viral sequence variation analysis.

Authors:  Jianjun Liu; Siew Lan Lim; Yijun Ruan; Ai Ee Ling; Lisa F P Ng; Christian Drosten; Edison T Liu; Lawrence W Stanton; Martin L Hibberd
Journal:  PLoS Med       Date:  2005-02-22       Impact factor: 11.069

View more
  128 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

2.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

3.  Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method.

Authors:  Yohei Kurosaki; Allen Grolla; Aiko Fukuma; Heinz Feldmann; Jiro Yasuda
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

4.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Authors:  Jens H Kuhn; Stephan Becker; Hideki Ebihara; Thomas W Geisbert; Karl M Johnson; Yoshihiro Kawaoka; W Ian Lipkin; Ana I Negredo; Sergey V Netesov; Stuart T Nichol; Gustavo Palacios; Clarence J Peters; Antonio Tenorio; Viktor E Volchkov; Peter B Jahrling
Journal:  Arch Virol       Date:  2010-10-30       Impact factor: 2.574

5.  Mechanism of human antibody-mediated neutralization of Marburg virus.

Authors:  Andrew I Flyak; Philipp A Ilinykh; Charles D Murin; Tania Garron; Xiaoli Shen; Marnie L Fusco; Takao Hashiguchi; Zachary A Bornholdt; James C Slaughter; Gopal Sapparapu; Curtis Klages; Thomas G Ksiazek; Andrew B Ward; Erica Ollmann Saphire; Alexander Bukreyev; James E Crowe
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

6.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

7.  Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

Authors:  Philipp A Ilinykh; Kai Huang; Rodrigo I Santos; Pavlo Gilchuk; Bronwyn M Gunn; Marcus M Karim; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Diptiben V Parekh; James B Kimble; Colette A Pietzsch; Michelle Meyer; Natalia A Kuzmina; Larry Zeitlin; Erica Ollmann Saphire; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

8.  Rapid molecular strategy for filovirus detection and characterization.

Authors:  Junhui Zhai; Gustavo Palacios; Jonathan S Towner; Omar Jabado; Vishal Kapoor; Marietjie Venter; Allen Grolla; Thomas Briese; Janusz Paweska; Robert Swanepoel; Heinz Feldmann; Stuart T Nichol; W Ian Lipkin
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

9.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

10.  Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012.

Authors:  C G Albariño; T Shoemaker; M L Khristova; J F Wamala; J J Muyembe; S Balinandi; A Tumusiime; S Campbell; D Cannon; A Gibbons; E Bergeron; B Bird; K Dodd; C Spiropoulou; B R Erickson; L Guerrero; B Knust; S T Nichol; P E Rollin; U Ströher
Journal:  Virology       Date:  2013-05-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.